Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

1.3K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.3K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

1.4K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.4K
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

2.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.2K
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

2.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.5K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

1.3K
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microscopic origin of quantum plasticity in small H<sub>3</sub><sup>+</sup>(H<sub>2</sub>)<sub><i>n</i></sub> (<i>n</i> = 1-3) clusters revealed by path integral molecular dynamics simulations.

Physical chemistry chemical physics : PCCP·2026
Same author

Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger-Mediated Negative Inotropy of Na<sup>+</sup> Channel Blockers Pilsicainide, Cibenzoline, and Propafenone in Guinea Pig Ventricular Myocardial Tissue Preparations.

Biological & pharmaceutical bulletin·2026
Same author

Possible Involvement of β<sub>1</sub>-Adrenoceptors in the Positive Chronotropic Effects of Mirabegron.

Biological & pharmaceutical bulletin·2026
Same author

Foreword.

Biological & pharmaceutical bulletin·2026
Same author

Nuclear quantum effects on intramolecular hydrogen bonds and backbone structures in biuret analogues.

Physical chemistry chemical physics : PCCP·2025
Same author

Nuclear quantum and H/D isotope effects on hydrogen-bond symmetrization in lithium hydroxide crystals at high pressure.

The Journal of chemical physics·2025

Related Experiment Video

Updated: Jan 7, 2026

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
09:50

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

9.7K

Chronotropic, Inotropic, and Lusitropic Effects of Flavonoids.

Kazuo Noguchi1, Chinami Ueda1, Saki Umeda1

  • 1Laboratory of Functional Food Sciences, Department of Health and Bio-Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University.

Biological & Pharmaceutical Bulletin
|January 4, 2026
PubMed
Summary

Flavonoids like polymethoxyflavones and quercetin impact heart muscle function, offering potential therapeutic benefits for heart conditions. Their specific effects vary based on chemical structure and cellular targets.

Keywords:
chronotropyflavonoidheartinotropylusitropy

More Related Videos

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
12:00

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

19.8K
Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
06:38

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on: February 28, 2025

645

Related Experiment Videos

Last Updated: Jan 7, 2026

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
09:50

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

9.7K
Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
12:00

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

19.8K
Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
06:38

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on: February 28, 2025

645

Area of Science:

  • Pharmacology
  • Cardiovascular Research
  • Natural Products Chemistry

Background:

  • Flavonoids are recognized for long-term antioxidant benefits.
  • Acute myocardial effects of flavonoids are under investigation.
  • Polymethoxyflavones and quercetin are key compounds studied.

Purpose of the Study:

  • To summarize recent findings on the acute myocardial effects of various flavonoids.
  • To explore the relationship between flavonoid chemical structure and cardiac activity.
  • To identify potential therapeutic applications for heart diseases.

Main Methods:

  • Review of recent scientific literature on flavonoid myocardial effects.
  • Analysis of structure-activity relationships for polymethoxyflavones.
  • Examination of quercetin's effects on cardiac sarcoplasmic reticulum Ca2+ ATPase.
  • Assessment of hesperetin's impact on pulmonary vein myocardium.

Main Results:

  • Polymethoxyflavones (sudachitin, demethoxysudachitin, nobiletin) exhibited mild chronotropic and inotropic effects, related to methoxy group number.
  • Sudachitin demonstrated significant vasorelaxant properties.
  • Quercetin enhanced Ca2+ sequestration in myocardium, showing positive lusitropic effects.
  • Hesperetin weakly inhibited action potential firing in pulmonary vein myocardium.

Conclusions:

  • Each flavonoid possesses distinct pharmacological effects on the heart, likely via specific cellular targets.
  • Flavonoid compounds show promise for developing novel therapeutic agents for heart failure and arrhythmia.
  • Further research is warranted to fully elucidate flavonoid mechanisms and therapeutic potential.